Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | RARB | P10826 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13033420 | 0.94 | AKR1C2 (0.35) | GRM2S1PR1S1PR3ALOX5APFEN1 | |
| SCHEMBL764861 | 0.92 | AKR1C2 (0.31) | RARB | |
| SCHEMBL18061215 | 0.91 | GRM2 (0.37) | GRM2S1PR1S1PR3ALOX5APFEN1 | |
| SCHEMBL12623676 | 0.90 | ALOX5AP (0.37) | GRM2S1PR1S1PR3ALOX5APFEN1 | |
| SCHEMBL1813180 | 0.89 | GRM2 (0.37) | GRM2S1PR1S1PR3ALOX5APFEN1 | |
| SCHEMBL13033413 | 0.89 | AKR1C2 (0.35) | GRM2S1PR1S1PR3ALOX5APFEN1 | |
| SCHEMBL3439493 | 0.89 | GRM2 (0.33) | GRM2S1PR1S1PR3RARB | |
| SCHEMBL12625449 | 0.88 | S1PR1 (0.33) | GRM2S1PR1S1PR3RARB | |
| SCHEMBL3439564 | 0.88 | RARB (0.35) | GRM2S1PR1S1PR3RARB | |
| SCHEMBL13033566 | 0.87 | CNR2 (0.32) | GRM2RARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586803-B2 | Chlorofluorobenzene compound, optically isotropic liquid crystal medium and optical device | JNC CORPORATION (JP) | 2013-11-19 | — | — | US | disclosed |
| US-8586153-B2 | Chlorofluorobenzene compound, optically isotropic liquid crystal medium and optical device | JNC CORPORATION (JP) | 2013-11-19 | — | — | US | disclosed |
| US-20130088658-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | HASEBA YASUHIRO (JP) | 2013-04-11 | — | — | US | disclosed |
| US-20130088658-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | HASEBA YASUHIRO (JP) | 2013-04-11 | — | — | US | disclosed |
| US-20130085306-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | HASEBA YASUHIRO (JP) | 2013-04-04 | — | — | US | disclosed |
| US-20130085306-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | HASEBA YASUHIRO (JP) | 2013-04-04 | — | — | US | disclosed |
| US-8343595-B2 | Chlorofluorobenzene compound, optically isotropic liquid crystal medium, and optical device | JNC CORPORATION (JP) | 2013-01-01 | — | — | US | disclosed |
| US-8343595-B2 | Chlorofluorobenzene compound, optically isotropic liquid crystal medium, and optical device | JNC CORPORATION (JP) | 2013-01-01 | — | — | US | disclosed |
| EP-2098583-B1 | Optically isotropic liquid crystal medium and optical device | JNC CORP (JP) | 2012-03-21 | — | — | EP | disclosed |
| US-20100296029-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM, AND OPTICAL DEVICE | CHISSO CORPORATION (JP) | 2010-11-25 | — | — | US | disclosed |
| US-20100296029-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM, AND OPTICAL DEVICE | CHISSO CORPORATION (JP) | 2010-11-25 | — | — | US | disclosed |
| US-7722783-B2 | Optically isotropic liquid crystal medium and optical device | CHISSO CORPORATION (JP) | 2010-05-25 | — | — | US | disclosed |
| US-7722783-B2 | Optically isotropic liquid crystal medium and optical device | CHISSO CORPORATION (JP) | 2010-05-25 | — | — | US | disclosed |
| EP-2098583-A2 | Optically isotropic liquid crystal medium and optical device | Chisso Corporation (JP) | 2009-09-09 | — | — | EP | disclosed |
| US-20090135368-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | CHISSO CORPORATION (JP) | 2009-05-28 | — | — | US | disclosed |
| US-20090135368-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | CHISSO CORPORATION (JP) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130085306-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | DDT, BRAF, CFAP410 | GRM2 3651/4885S1PR1 4560/4885S1PR3 4443/4885 |
| US-20100296029-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM, AND OPTICAL DEVICE | DDT, BRAF, LEF1 | GRM2 3659/4885S1PR1 4543/4885S1PR3 4458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.